SCHEMBL27698653

SCHEMBL27698653

O=CC(Cc1ccc(F)cc1)N1CCC(c2nc(C(=O)N3CCN(c4ccccc4)CC3)cs2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
POLB P06746 4/20 0.42
TSHR P16473 4/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MAPT P10636 4/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.39
LMNA P02545 4/20 0.39
KMT2A Q03164 1/20 0.39
RAB9A P51151 1/20 0.39
PRKAA2 P54646 1/20 0.39
MAPK1 P28482 2/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
SCD O00767 2/20 0.38
SCD5 Q86SK9 1/20 0.38
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27698608 0.91 MEN1 (0.45) PTGS1PTGS2POLBTSHRNPSR1
SCHEMBL27679669 0.89 KMT2A (0.43) POLBTSHRNPSR1MAPTALDH1A1
SCHEMBL27698652 0.88 PTGS1 (0.43) PTGS1PTGS2POLBTSHRNPSR1
SCHEMBL27698605 0.84 PPARG (0.36) TSHRRAB9APRKAA2MAPK1CYP3A4
SCHEMBL2186625 0.83 MAPT (0.56) PTGS1PTGS2POLBTSHRNPSR1
SCHEMBL27679766 0.81 LMNA (0.43) POLBTSHRNPSR1MAPTALDH1A1
SCHEMBL27698640 0.81 PPARG (0.32) LMNAKMT2A
SCHEMBL27698606 0.80 MEN1 (0.46) PTGS1PTGS2POLBTSHRNPSR1
SCHEMBL27679665 0.78 LMNA (0.46) POLBTSHRNPSR1MAPTALDH1A1
SCHEMBL27698639 0.78 KMT2A (0.46) NPSR1MAPTALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101031567-B Novel heterocyclic NF-kB inhibitors 4SC Corp.,Ltd. (DE) 2011-12-21 CN disclosed
CN-101031567-A Novel heterocyclic NF-kB inhibitors 4SC AG (DE) 2007-09-05 CN disclosed